Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.
Ronald W.  Penczek net worth and biography

Ronald Penczek Biography and Net Worth

Ronald W. Penczek is a Senior Vice President, Chief Accounting Officer, Controller of the Company. Prior to that appointment, Mr. Penczek served as Vice President and Assistant Controller from January 2008 to August 2013 and in various other roles in our finance department from February 2006 until January 2008. Before joining us, Mr. Penczek was a Staff Vice President with CNA Insurance from 2000 to 2005 and had various positions with PricewaterhouseCoopers LLP from 1992 to 2000, including as a Manager.

What is Ronald W. Penczek's net worth?

The estimated net worth of Ronald W. Penczek is at least $1.46 million as of October 24th, 2023. Mr. Penczek owns 2,842 shares of Elevance Health stock worth more than $1,458,372 as of February 26th. This net worth approximation does not reflect any other assets that Mr. Penczek may own. Learn More about Ronald W. Penczek's net worth.

How old is Ronald W. Penczek?

Mr. Penczek is currently 59 years old. There are 5 older executives and no younger executives at Elevance Health. The oldest executive at Elevance Health is Ms. Felicia Farr Norwood, Executive VP & President of Government Health Benefits, who is 64 years old. Learn More on Ronald W. Penczek's age.

How do I contact Ronald W. Penczek?

The corporate mailing address for Mr. Penczek and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Ronald W. Penczek's contact information.

Has Ronald W. Penczek been buying or selling shares of Elevance Health?

Ronald W. Penczek has not been actively trading shares of Elevance Health during the last ninety days. Most recently, Ronald W. Penczek sold 64 shares of the business's stock in a transaction on Tuesday, October 24th. The shares were sold at an average price of $454.35, for a transaction totalling $29,078.40. Following the completion of the sale, the chief accounting officer now directly owns 2,842 shares of the company's stock, valued at $1,291,262.70. Learn More on Ronald W. Penczek's trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (CEO), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, insiders at the sold shares 4 times. They sold a total of 16,225 shares worth more than $7,268,344.98. The most recent insider tranaction occured on February, 7th when Director Ramiro G Peru sold 753 shares worth more than $376,500.00. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 2/7/2024.

Ronald W. Penczek Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/24/2023Sell64$454.35$29,078.402,842View SEC Filing Icon  
3/3/2022Sell2,423$463.68$1,123,496.64View SEC Filing Icon  
2/7/2022Sell2,763$453.48$1,252,965.24View SEC Filing Icon  
10/28/2021Sell1,150$436.00$501,400.00View SEC Filing Icon  
3/5/2021Sell2,068$333.94$690,587.923,137View SEC Filing Icon  
11/13/2019Sell816$287.00$234,192.002,295View SEC Filing Icon  
5/30/2019Sell763$279.00$212,877.002,295View SEC Filing Icon  
9/4/2018Sell763$265.56$202,622.281,334View SEC Filing Icon  
3/7/2018Sell1,966$231.90$455,915.402,132View SEC Filing Icon  
11/7/2017Sell978$217.42$212,636.761,222View SEC Filing Icon  
6/7/2017Sell867$187.46$162,527.821,872View SEC Filing Icon  
3/6/2017Sell729$165.56$120,693.241,448View SEC Filing Icon  
3/2/2017Sell1,213$166.56$202,037.281,248View SEC Filing Icon  
11/22/2016Sell820$138.29$113,397.801,320View SEC Filing Icon  
8/3/2016Sell552$128.37$70,860.242,407View SEC Filing Icon  
See Full Table

Ronald W. Penczek Buying and Selling Activity at Elevance Health

This chart shows Ronald W Penczek's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.
Read More

Today's Range

Now: $513.15
Low: $511.60
High: $516.61

50 Day Range

MA: $485.00
Low: $459.19
High: $514.09

2 Week Range

Now: $513.15
Low: $412.00
High: $516.61

Volume

78,181 shs

Average Volume

1,053,941 shs

Market Capitalization

$119.39 billion

P/E Ratio

20.39

Dividend Yield

1.15%

Beta

0.78
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Learn more here.